NASDAQ · PWP

Perella Weinberg Partners

$15.67 +$0.71 (+4.75%) 1D After hours

Key Metrics

$1.09B
Market cap
55.60×
P/E · TTM
$687.99M
Revenue · TTM
$19.63M
Net income
EPS · TTM $0.26
Dividend yield 2.1%
Free cash flow $96.27M
Beta · 1Y 1.52
EBITDA · TTM $42.37M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 8
    The stock moved -8.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 8
  • Jun 10
    From its Feb 9 high, the share price fell 40%.

    Peak close $24.34 on Feb 9; trough close $14.71 on Jun 10. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -40%
  • May 1
    The stock moved -9.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 1

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.09B
Enterprise value
Shares outstanding72.9M
52-wk range$14.54 – $25.93
Avg volume · 20D597.0K
Net cash
Book value / share$-2.04
IndustryFinance Services
ExchangeNASDAQ
About Perella Weinberg Partners
IPO dateJun 25, 2021
Employees736

Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E55.60
P/S1.59
P/FCF11.33
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating 4.2%
Net 2.9%
FCF 14.0%
ROE / ROIC -6.8% · -11.1%

Financial Health

Current ratio
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital

Cash Flow · TTM

Operating CF $101.60M
Capex −$5.33M
Free cash flow $96.27M
Buybacks
Dividends paid $23.20M
Shareholder yield 2.1%

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

2.8
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings